Elina Vahtera

3.7k total citations
57 papers, 1.9k citations indexed

About

Elina Vahtera is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Internal Medicine. According to data from OpenAlex, Elina Vahtera has authored 57 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 21 papers in Pulmonary and Respiratory Medicine and 10 papers in Internal Medicine. Recurrent topics in Elina Vahtera's work include Blood Coagulation and Thrombosis Mechanisms (18 papers), Blood properties and coagulation (16 papers) and Venous Thromboembolism Diagnosis and Management (10 papers). Elina Vahtera is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (18 papers), Blood properties and coagulation (16 papers) and Venous Thromboembolism Diagnosis and Management (10 papers). Elina Vahtera collaborates with scholars based in Finland, United States and Sweden. Elina Vahtera's co-authors include G. Myllylä, Seppo Hiippala, Vesa Rasi, Veikko Salomaa, Juha Pekkanen, Anne Kuitunen, Jari Petäjä, P Myllynen, Pekka Jousilahti and Christian Ehnholm and has published in prestigious journals such as Blood, Biochemical Journal and European Heart Journal.

In The Last Decade

Elina Vahtera

57 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elina Vahtera Finland 19 670 501 495 428 415 57 1.9k
Marie‐Geneviève Huisse France 17 408 0.6× 254 0.5× 318 0.6× 141 0.3× 384 0.9× 30 1.5k
Ramiro Arellano Canada 20 546 0.8× 225 0.4× 231 0.5× 648 1.5× 721 1.7× 40 1.8k
Debra L. Malone United States 19 838 1.3× 200 0.4× 222 0.4× 597 1.4× 998 2.4× 32 2.4k
Thomas Pernerstorfer Austria 23 227 0.3× 409 0.8× 395 0.8× 79 0.2× 354 0.9× 58 1.7k
James B. Haenel United States 25 865 1.3× 830 1.7× 82 0.2× 235 0.5× 860 2.1× 47 2.6k
Jason L. Sperry United States 29 908 1.4× 365 0.7× 130 0.3× 307 0.7× 1.1k 2.6× 76 2.6k
Alexander Spiel Austria 25 446 0.7× 335 0.7× 450 0.9× 59 0.1× 408 1.0× 81 2.6k
Frederick A. Moore United States 17 1.1k 1.6× 335 0.7× 216 0.4× 166 0.4× 1.1k 2.6× 22 2.5k
S. B. Nadler United States 6 200 0.3× 194 0.4× 352 0.7× 605 1.4× 899 2.2× 12 1.8k
Martti Syrjälä Finland 19 96 0.1× 296 0.6× 358 0.7× 136 0.3× 202 0.5× 49 1.2k

Countries citing papers authored by Elina Vahtera

Since Specialization
Citations

This map shows the geographic impact of Elina Vahtera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elina Vahtera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elina Vahtera more than expected).

Fields of papers citing papers by Elina Vahtera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elina Vahtera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elina Vahtera. The network helps show where Elina Vahtera may publish in the future.

Co-authorship network of co-authors of Elina Vahtera

This figure shows the co-authorship network connecting the top 25 collaborators of Elina Vahtera. A scholar is included among the top collaborators of Elina Vahtera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elina Vahtera. Elina Vahtera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Levo, Antti, Elina Vahtera, Vesa Rasi, et al.. (2005). Genetic background of type I protein C deficiency in Finland. Thrombosis Research. 118(5). 603–609. 5 indexed citations
2.
Ebeling, Freja, et al.. (2003). Infant stroke and beta-2-glycoprotein 1 antibodies: six cases. European Journal of Pediatrics. 162(10). 678–681. 14 indexed citations
3.
Ebeling, Freja, et al.. (2003). Beta‐2‐glycoprotein I antibodies in patients with thrombosis. Scandinavian Journal of Clinical and Laboratory Investigation. 63(2). 111–118. 13 indexed citations
4.
Jousilahti, Pekka, et al.. (2002). The association of sensitive systemic inflammation markers with bronchial asthma. Annals of Allergy Asthma & Immunology. 89(4). 381–385. 122 indexed citations
5.
6.
Kekomäki, Riitta, Vesa Rasi, Freja Ebeling, et al.. (1999). von Willebrand disease in Finland. Haemophilia. 5(s2). 72–74. 5 indexed citations
7.
Jousilahti, Pekka, Veikko Salomaa, Vesa Rasi, & Elina Vahtera. (1999). Symptoms of chronic bronchitis, haemostatic factors, and coronary heart disease risk. Atherosclerosis. 142(2). 403–407. 15 indexed citations
8.
Salomaa, Veikko, Vesa Rasi, Jari Stengård, et al.. (1998). Intra- and Interindividual Variability of Hemostatic Factors and Traditional Cardiovascular Risk Factors in a Three-year Follow-up. Thrombosis and Haemostasis. 79(5). 969–974. 23 indexed citations
9.
Niskanen, Leo, Ursula Schwab, Essi Sarkkinen, et al.. (1997). Effects of dietary fat modification on fibrinogen, factor VII, and plasminogen activator inhibitor-1 activity in subjects with impaired glucose tolerance. Metabolism. 46(6). 666–672. 16 indexed citations
10.
Hiippala, Seppo, G. Myllylä, & Elina Vahtera. (1995). Hemostatic Factors and Replacement of Major Blood Loss with Plasma-Poor Red Cell Concentrates. Anesthesia & Analgesia. 81(2). 360–365. 107 indexed citations
11.
Hessel, B., Angela Silveira, Kjell Carlsson, et al.. (1995). Fibrinogenemia Tampere — A dysfibrinogenemia with defective gelation and thromboembolic disease. Thrombosis Research. 78(4). 323–339. 8 indexed citations
12.
Myllykangas, Markku, Juha Pekkanen, Vesa Rasi, et al.. (1995). Haemostatic and Other Cardiovascular Risk Factors, and Socioeconomic Status among Middle-Aged Finnish Men and Women. International Journal of Epidemiology. 24(6). 1110–1116. 32 indexed citations
13.
Hiippala, Seppo, G. Myllylä, & Elina Vahtera. (1995). Hemostatic Factors and Replacement of Major Blood Loss with Plasma-Poor Red Cell Concentrates. Anesthesia & Analgesia. 81(2). 360–365. 486 indexed citations
14.
Mutanen, Marja, Tom Krusius, Leena Räsänen, et al.. (1995). Habitual diet, platelet function, fibrinogen and facto VII coagulant activity in young Finns. Journal of Internal Medicine. 237(6). 577–583. 8 indexed citations
15.
Haglund, Caj, et al.. (1995). Cellular fibronectin in serum and plasma: a potential new tumour marker?. British Journal of Cancer. 71(3). 578–582. 24 indexed citations
16.
Krusius, Tom, et al.. (1994). Short-term aspirin treatment does not reduce plasma fibrinogen concentration in young healthy adults. Thrombosis Research. 75(6). 653–656. 6 indexed citations
17.
Vahtera, Elina, et al.. (1988). Decrease of plasma prekallikrein and kallikrein inhibitors during intravenous phlebography.. PubMed. 8(1). 30–3. 3 indexed citations
18.
Myllynen, P, P Rokkanen, Ole Böstman, et al.. (1987). The blood F VIII:Ag/F VIII:C ratio as an early indicator of deep venous thrombosis during post-traumatic immobilization.. PubMed. 27(3). 287–90. 16 indexed citations
19.
Vahtera, Elina, et al.. (1979). Amidase activity in FVIII concentrate associated with α2M. Thrombosis Research. 16(5-6). 859–864. 3 indexed citations
20.
Vahtera, Elina & Ulla Hamberg. (1978). Interaction of urokinase with α2-macroglobulin investigated by isoelectric focusing. Evidence for non-specific dissociable binding. Biochemical Journal. 171(3). 767–770. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie‐Geneviève Huisse Breakdown of academic impact, for papers by Ramiro Arellano Breakdown of academic impact, for papers by Debra L. Malone Breakdown of academic impact, for papers by Thomas Pernerstorfer Breakdown of academic impact, for papers by James B. Haenel Breakdown of academic impact, for papers by Jason L. Sperry Breakdown of academic impact, for papers by Alexander Spiel Breakdown of academic impact, for papers by Frederick A. Moore Breakdown of academic impact, for papers by S. B. Nadler Breakdown of academic impact, for papers by Martti Syrjälä
Rankless by CCL
2026